CNCT19 CAR T-Cell Therapy in Relapsed or Refractory B-Cell Lymphoma: Long-Term Results of a Pilot Prospective Clinical Study

被引：1
|
作者：
Liu, Wei [1 ]
Huang, Wenyang [1 ]
Lv, Rui [1 ]
Liu, Huimin [1 ]
Yi, Shuhua [1 ]
Liu, Hong [1 ]
Lv, Lulu [2 ]
Qiu, Lugui [1 ]
Wang, Jianxiang [1 ]
Zou, Dehui [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis, Haihe Lab Cell Ecosyst,State Key Lab Expt Hematol, Tianjin, Peoples R China
[2] Juventas Cell Therapy Ltd, Tianjin, Peoples R China
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-167104
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4598 / 4599
页数：2
相关论文
共 50 条
  • [1] Anti-CD19 CAR T-Cell (CNCT19) Infusion Following HDT/ASCT Is Safe and Effective in Patients with Relapsed/Refractory Large B-Cell Lymphoma
    Liu, Wei
    Huang, Wenyang
    Lv, Ryu
    Deng, Shuhui
    Yi, Shuhua
    Liu, Huimin
    Lv, Lulu
    Qiu, Lugui
    Zou, Dehui
    Wang, Jianxiang
    BLOOD, 2020, 136
  • [2] CAR T-Cell Therapy for Relapsed/Refractory Aggressive Large B-Cell Lymphoma
    Gideon, Jacklyn
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2022, 26 (06) : 597 - 601
  • [3] CAR T-cell therapy in refractory large B-cell lymphoma
    Stirrups, Robert
    LANCET ONCOLOGY, 2018, 19 (01): : E19 - E19
  • [4] Axicabtagene Ciloleucel: Clinical Data for the Use of CAR T-cell Therapy in Relapsed and Refractory Large B-cell Lymphoma
    Halford, Zachery
    Anderson, Mary Kate
    Bennett, Lunawati L.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (03) : 390 - 405
  • [5] Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma
    Chow, Victor A.
    Shadman, Mazyar
    Gopal, Ajay K.
    BLOOD, 2018, 132 (08) : 777 - 781
  • [6] Long term neurological safety in B-cell lymphoma patients treated with CAR T-cell therapy: a prospective cohort study
    Ursu, R.
    Maillet, D.
    Belin, C.
    Moroni, C.
    Cuzzubbo, S.
    Vernier, V.
    Sirven-Villaros, L.
    Carreau, C.
    Di Blasi, R.
    Thieblemont, C.
    Carpentier, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 167 - 168
  • [7] Proton Therapy as a Bridging Treatment in CAR T-Cell Therapy for Relapsed and Refractory Large B-Cell Lymphoma: Is There a Role?
    Saifi, Omran
    Kharfan-Dabaja, Mohamed A.
    Zeidan, Youssef H.
    Peterson, Jennifer
    Rule, William G.
    Lester, Scott C.
    Hoppe, Bradford S.
    INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2020, 7 (01) : 13 - 20
  • [8] Salvage Radiotherapy in Relapsed/ Refractory Large B-Cell Lymphoma After CAR T-Cell Therapy Failure
    Ababneh, Hazim
    Ng, Andrea
    Frigault, Matthew
    Abramson, Jeremy
    Johnson, Patrick
    Jacobson, Caron
    Patel, Chirayu
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S414 - S414
  • [9] Salvage radiotherapy in relapsed/refractory large B-cell lymphoma after failure of CAR T-cell therapy
    Ababneh, Hazim S.
    Ng, Andrea K.
    Frigault, Matthew J.
    Abramson, Jeremy S.
    Johnson, Patrick Connor
    Jacobson, Caron A.
    Patel, C. G.
    HAEMATOLOGICA, 2023, 108 (11) : 2972 - 2981
  • [10] Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma
    Ladbury, Colton
    Dandapani, Savita
    Hao, Claire
    Fabros, Mildred
    Amini, Arya
    Sampath, Sagus
    Glaser, Scott
    Sokolov, Karen
    Yeh, Jekwon
    Baird, John H.
    Kambhampati, Swetha
    Herrera, Alex
    Mei, Matthew
    Nikolaenko, Liana
    Shouse, Geoffrey
    Budde, Lihua E.
    CANCERS, 2023, 15 (06)
12345